Compass Therapeutics, Inc.
CMPX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $46 | $23 | $41 | $43 |
| Short-Term Investments | $174 | $78 | $72 | $83 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $5 | $12 | $6 |
| Total Curr. Assets | $221 | $106 | $124 | $133 |
| Property Plant & Equip (Net) | $10 | $10 | $7 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $1 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $1 | $1 |
| Total NC Assets | $10 | $11 | $7 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $231 | $117 | $131 | $140 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $2 | $2 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $9 | $11 | $13 | $6 |
| Total Curr. Liab. | $12 | $14 | $15 | $9 |
| LT Debt | $9 | $10 | $6 | $6 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $9 | $10 | $6 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $10 | $0 | $6 | $7 |
| Total Liabilities | $22 | $23 | $21 | $15 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$415 | -$401 | -$381 | -$365 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $625 | $494 | $491 | $490 |
| Total Equity | $210 | $93 | $110 | $125 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $231 | $117 | $131 | $140 |
| Net Debt | -$36 | -$13 | -$35 | -$37 |